These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 9401498

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.
    Cazzola M, Messinger D, Battistel V, Bron D, Cimino R, Enller-Ziegler L, Essers U, Greil R, Grossi A, Jäger G, LeMevel A, Najman A, Silingardi V, Spriano M, van Hoof A, Ehmer B.
    Blood; 1995 Dec 15; 86(12):4446-53. PubMed ID: 8541533
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.
    Varan A, Büyükpamukçu M, Kutluk T, Akyüz C.
    Pediatrics; 1999 Feb 15; 103(2):E16. PubMed ID: 9925862
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
    Case DC, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ, Jones SE, Keller AM, Kugler JW, Nichols CR.
    J Natl Cancer Inst; 1993 May 19; 85(10):801-6. PubMed ID: 8487324
    [Abstract] [Full Text] [Related]

  • 5. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
    Abdelrazik N, Fouda M.
    Hematology; 2007 Dec 19; 12(6):533-41. PubMed ID: 17852440
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum erythropoietin and creatinine concentrations as predictive factors for response to recombinant human erythropoietin treatment in anaemic tumour patients on chemotherapy.
    Fjornes T, Wiedemann GJ, Sack K, Jelkmann W.
    Oncol Rep; 1998 Dec 19; 5(1):81-6. PubMed ID: 9458299
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of erythropoietin administration in the treatment of anemia immediately after renal transplantation.
    Van Biesen W, Vanholder R, Veys N, Verbeke F, Lameire N.
    Transplantation; 2005 Feb 15; 79(3):367-8. PubMed ID: 15699772
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA, Khan ZK, Hakimali A, Sabih M, Rehman G.
    J Pak Med Assoc; 1998 May 15; 48(5):127-31. PubMed ID: 9813972
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The level of erythropoietin in patients with anemia and myeloma multiplex treated with erythropoietin].
    Ciepłuch H, Zaucha JM, Lysiak-Szydłowska W, Hellmann A.
    Pol Arch Med Wewn; 1995 Aug 15; 94(2):153-8. PubMed ID: 8596750
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.
    Osterborg A, Brandberg Y, Molostova V, Iosava G, Abdulkadyrov K, Hedenus M, Messinger D, Epoetin Beta Hematology Study Group.
    J Clin Oncol; 2002 May 15; 20(10):2486-94. PubMed ID: 12011126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.